Annual Cash & Cash Equivalents
$26.28 M
-$16.80 M-39.00%
December 31, 2023
Summary
- As of February 7, 2025, BDSX annual cash & cash equivalents is $26.28 million, with the most recent change of -$16.80 million (-39.00%) on December 31, 2023.
- During the last 3 years, BDSX annual cash & cash equivalents has fallen by -$35.84 million (-57.69%).
- BDSX annual cash & cash equivalents is now -57.69% below its all-time high of $62.13 million, reached on December 31, 2020.
Performance
BDSX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$31.41 M
-$10.81 M-25.61%
September 30, 2024
Summary
- As of February 7, 2025, BDSX quarterly cash and cash equivalents is $31.41 million, with the most recent change of -$10.81 million (-25.61%) on September 30, 2024.
- Over the past year, BDSX quarterly cash and cash equivalents has increased by +$11.56 million (+58.29%).
- BDSX quarterly cash and cash equivalents is now -49.45% below its all-time high of $62.13 million, reached on December 31, 2020.
Performance
BDSX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BDSX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.0% | +58.3% |
| 3 y3 years | -57.7% | +58.3% |
| 5 y5 years | +344.4% | +58.3% |
BDSX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.0% | at low | -27.1% | +173.3% |
| 5 y | 5-year | -57.7% | +397.2% | -49.5% | +494.1% |
| alltime | all time | -57.7% | +397.2% | -49.5% | +494.1% |
Biodesix Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $31.41 M(-25.6%) |
| Jun 2024 | - | $42.22 M(+267.4%) |
| Mar 2024 | - | $11.49 M(-56.3%) |
| Dec 2023 | $26.28 M(-39.0%) | $26.28 M(+32.5%) |
| Sep 2023 | - | $19.84 M(+14.0%) |
| Jun 2023 | - | $17.41 M(-31.1%) |
| Mar 2023 | - | $25.27 M(-41.3%) |
| Dec 2022 | $43.09 M | $43.09 M(+183.9%) |
| Sep 2022 | - | $15.18 M(-35.7%) |
| Jun 2022 | - | $23.59 M(+43.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $16.43 M(-49.8%) |
| Dec 2021 | $32.71 M(-47.3%) | $32.71 M(-31.7%) |
| Sep 2021 | - | $47.91 M(-15.0%) |
| Jun 2021 | - | $56.35 M(+1.8%) |
| Mar 2021 | - | $55.33 M(-10.9%) |
| Dec 2020 | $62.13 M(+1075.3%) | $62.13 M(+878.7%) |
| Sep 2020 | - | $6.35 M(-45.6%) |
| Jun 2020 | - | $11.67 M(+120.8%) |
| Dec 2019 | $5.29 M(-10.6%) | $5.29 M |
| Dec 2018 | $5.91 M | - |
FAQ
- What is Biodesix annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Biodesix?
- What is Biodesix annual cash & cash equivalents year-on-year change?
- What is Biodesix quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Biodesix?
- What is Biodesix quarterly cash and cash equivalents year-on-year change?
What is Biodesix annual cash & cash equivalents?
The current annual cash & cash equivalents of BDSX is $26.28 M
What is the all time high annual cash & cash equivalents for Biodesix?
Biodesix all-time high annual cash & cash equivalents is $62.13 M
What is Biodesix annual cash & cash equivalents year-on-year change?
Over the past year, BDSX annual cash & cash equivalents has changed by -$16.80 M (-39.00%)
What is Biodesix quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BDSX is $31.41 M
What is the all time high quarterly cash and cash equivalents for Biodesix?
Biodesix all-time high quarterly cash and cash equivalents is $62.13 M
What is Biodesix quarterly cash and cash equivalents year-on-year change?
Over the past year, BDSX quarterly cash and cash equivalents has changed by +$11.56 M (+58.29%)